Progression-free survival at 2 years is a reliable surrogate marker for the 5-year survival rate in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy

Định dạng: PDF / Số trang: 5

Nhắn tin với admin nếu không tải được